Global Specific Antiviral Drugs for COVID-19 Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Specific Antiviral Drugs for COVID-19 Market Size 2022-2028

2.1.2 Specific Antiviral Drugs for COVID-19 Market Size CAGR by Region

2.2 Specific Antiviral Drugs for COVID-19 Segment by Type

2.2.1 Tablet

2.2.2 Injection

2.3 Specific Antiviral Drugs for COVID-19 Market Size by Type

2.3.1 Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

2.3.2 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type (2022-2028)

2.4 Specific Antiviral Drugs for COVID-19 Segment by Application

2.4.1 Mild Symptom Patient

2.4.2 Critically Ill Patient

2.5 Specific Antiviral Drugs for COVID-19 Market Size by Application

2.5.1 Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

2.5.2 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Application (2022-2028)

3 Specific Antiviral Drugs for COVID-19 Key Players

3.1 Date of Key Players Enter into Specific Antiviral Drugs for COVID-19

3.2 Key Players Specific Antiviral Drugs for COVID-19 Product Offered

3.3 Key Players Specific Antiviral Drugs for COVID-19 Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players Specific Antiviral Drugs for COVID-19 Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 Specific Antiviral Drugs for COVID-19 by Regions

4.1 Specific Antiviral Drugs for COVID-19 Market Size by Regions (2022-2028)

4.2 United States Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)

4.3 China Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)

4.4 Europe Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)

4.5 Rest of World Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)

5 United States

5.1 United States Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)

5.2 United States Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)

6 China

6.1 China Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)

6.2 China Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)

7 Europe

7.1 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)

7.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)

8 Rest of World

8.1 Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)

8.2 Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Key Investors in Specific Antiviral Drugs for COVID-19

10.1 Company A

10.1.1 Company A Company Details

10.1.2 Company Description

10.1.3 Companies Invested by Company A

10.1.4 Company A Key Development and Market Layout

10.2 Company B

10.2.1 Company B Company Details

10.2.2 Company Description

10.2.3 Companies Invested by Company B

10.2.4 Company B Key Development and Market Layout

10.3 Company C

10.3.1 Company C Company Details

10.3.2 Company Description

10.3.3 Companies Invested by Company C

10.3.4 Company C Key Development and Market Layout

10.4 Company D

10.5 ……

11 Key Players Analysis

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Specific Antiviral Drugs for COVID-19 Product Offered

11.1.3 Sanofi Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.1.4 Sanofi Main Business Overview

11.1.5 Sanofi News

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Specific Antiviral Drugs for COVID-19 Product Offered

11.2.3 Novartis Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis News

11.3 Shanghai Zhongxisanwei

11.3.1 Shanghai Zhongxisanwei Company Details

11.3.2 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product Offered

11.3.3 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.3.4 Shanghai Zhongxisanwei Main Business Overview

11.3.5 Shanghai Zhongxisanwei News

11.4 Teva

11.4.1 Teva Company Details

11.4.2 Teva Specific Antiviral Drugs for COVID-19 Product Offered

11.4.3 Teva Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.4.4 Teva Main Business Overview

11.4.5 Teva News

11.5 Zydus Cadila

11.5.1 Zydus Cadila Company Details

11.5.2 Zydus Cadila Specific Antiviral Drugs for COVID-19 Product Offered

11.5.3 Zydus Cadila Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.5.4 Zydus Cadila Main Business Overview

11.5.5 Zydus Cadila News

11.6 Mylan

11.6.1 Mylan Company Details

11.6.2 Mylan Specific Antiviral Drugs for COVID-19 Product Offered

11.6.3 Mylan Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.6.4 Mylan Main Business Overview

11.6.5 Mylan News

11.7 Apotex

11.7.1 Apotex Company Details

11.7.2 Apotex Specific Antiviral Drugs for COVID-19 Product Offered

11.7.3 Apotex Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.7.4 Apotex Main Business Overview

11.7.5 Apotex News

11.8 Advanz Pharma

11.8.1 Advanz Pharma Company Details

11.8.2 Advanz Pharma Specific Antiviral Drugs for COVID-19 Product Offered

11.8.3 Advanz Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.8.4 Advanz Pharma Main Business Overview

11.8.5 Advanz Pharma News

11.9 Sun Pharma

11.9.1 Sun Pharma Company Details

11.9.2 Sun Pharma Specific Antiviral Drugs for COVID-19 Product Offered

11.9.3 Sun Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.9.4 Sun Pharma Main Business Overview

11.9.5 Sun Pharma News

11.10 Kyung Poong

11.10.1 Kyung Poong Company Details

11.10.2 Kyung Poong Specific Antiviral Drugs for COVID-19 Product Offered

11.10.3 Kyung Poong Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

11.10.4 Kyung Poong Main Business Overview

11.10.5 Kyung Poong News

11.11 Ipca Laboratories

11.12 Hanlim Pharmaceutical

11.13 Bristol Laboratories

11.14 Bayer

11.15 Rising Pharmaceutical

11.16 Shanghai Pharma

11.17 Sichuan Sunny Hope

11.18 Guangzhou Baiyunshan Guanghua Pharmaceutical

11.19 CSPC Group

11.20 KPC Group

11.21 Jinghua Pharmaceutical Group

11.22 Zhongsheng Pharma

11.23 North China Pharmaceutical Group

12 Research Findings and Conclusion

Table 1. Specific Antiviral Drugs for COVID-19 Market Size CAGR by Region (2022-2028) ($ Millions)

Table 2. Major Players of Tablet

Table 3. Major Players of Injection

Table 4. Global Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)

Table 5. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

Table 6. Global Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)

Table 7. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

Table 8. Date of Global Key Players Enter into Specific Antiviral Drugs for COVID-19 Market

Table 9. Global Key Players Specific Antiviral Drugs for COVID-19 Product Offered

Table 10. Key Players Specific Antiviral Drugs for COVID-19 Funding/Investment ($ Millions)

Table 11. Funding/Investment by Regions

Table 12. Funding/Investment by End Industry

Table 13. Key Players Specific Antiviral Drugs for COVID-19 Valuation & Market Capitalization ($ Millions)

Table 14. Key Players Mergers & Acquisitions, Expansion Plans

Table 15. Specific Antiviral Drugs for COVID-19 New Product/Technology Launches

Table 16. Specific Antiviral Drugs for COVID-19 Industry Partnerships, Agreements, and Collaborations

Table 17. Specific Antiviral Drugs for COVID-19 Industry Mergers and Acquisitions

Table 18. Global Specific Antiviral Drugs for COVID-19 Market Size by Regions 2022-2028 ($ Millions)

Table 19. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Regions 2022-2028

Table 20. United States Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)

Table 21. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

Table 22. United States Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)

Table 23. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

Table 24. China Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)

Table 25. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

Table 26. China Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)

Table 27. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

Table 28. Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)

Table 29. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

Table 30. Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)

Table 31. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

Table 32. Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)

Table 33. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

Table 34. Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)

Table 35. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

Table 36. Key Market Drivers & Growth Opportunities of Specific Antiviral Drugs for COVID-19

Table 37. Key Market Challenges & Risks of Specific Antiviral Drugs for COVID-19

Table 38. Key Industry Trends of Specific Antiviral Drugs for COVID-19

Table 39. Company A Company Details

Table 40. Companies Invested by Company A

Table 41. Company A Key Development and Market Layout

Table 42. Company B Company Details

Table 43. Companies Invested by Company B

Table 44. Company B Key Development and Market Layout

Table 45. Company C Company Details

Table 46. Companies Invested by Company C

Table 47. Company C Key Development and Market Layout

Table 48. Company C Company Details

Table 49. Companies Invested by Company C

Table 50. Company C Key Development and Market Layout

Table 51. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors

Table 52. Sanofi Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 53. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors

Table 54. Novartis Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 55. Shanghai Zhongxisanwei Basic Information, Head Office, Major Market Areas and Its Competitors

Table 56. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 57. Teva Basic Information, Head Office, Major Market Areas and Its Competitors

Table 58. Teva Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 59. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors

Table 60. Zydus Cadila Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 61. Mylan Basic Information, Head Office, Major Market Areas and Its Competitors

Table 62. Mylan Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 63. Apotex Basic Information, Head Office, Major Market Areas and Its Competitors

Table 64. Apotex Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 65. Advanz Pharma Basic Information, Head Office, Major Market Areas and Its Competitors

Table 66. Advanz Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 67. Sun Pharma Basic Information, Head Office, Major Market Areas and Its Competitors

Table 68. Sun Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 69. Kyung Poong Basic Information, Head Office, Major Market Areas and Its Competitors

Table 70. Kyung Poong Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 71. Ipca Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors

Table 72. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 73. Hanlim Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors

Table 74. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 75. Bristol Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors

Table 76. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 77. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors

Table 78. Bayer Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 79. Rising Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors

Table 80. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 81. Shanghai Pharma Basic Information, Head Office, Major Market Areas and Its Competitors

Table 82. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 83. Sichuan Sunny Hope Basic Information, Head Office, Major Market Areas and Its Competitors

Table 84. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 85. Guangzhou Baiyunshan Guanghua Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors

Table 86. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 87. CSPC Group Basic Information, Head Office, Major Market Areas and Its Competitors

Table 88. CSPC Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 89. KPC Group Basic Information, Head Office, Major Market Areas and Its Competitors

Table 90. KPC Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 91. Jinghua Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors

Table 92. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 93. Zhongsheng Pharma Basic Information, Head Office, Major Market Areas and Its Competitors

Table 94. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

Table 95. North China Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors

Table 96. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)

List of Figures

Figure 1. Picture of Specific Antiviral Drugs for COVID-19

Figure 2. Specific Antiviral Drugs for COVID-19 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate 2022-2028 ($ Millions)

Figure 7. Specific Antiviral Drugs for COVID-19 Market Size by Region (2022 & 2027) ($ millions)

Figure 8. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)

Figure 9. Global Tablet Market Size Growth Rate

Figure 10. Global Injection Market Size Growth Rate

Figure 11. Specific Antiviral Drugs for COVID-19 in Mild Symptom Patient

Figure 12. Global Specific Antiviral Drugs for COVID-19 Market: Mild Symptom Patient (2022-2028) ($ Millions)

Figure 13. Specific Antiviral Drugs for COVID-19 in Critically Ill Patient

Figure 14. Global Specific Antiviral Drugs for COVID-19 Market: Critically Ill Patient (2022-2028) ($ Millions)

Figure 15. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)

Figure 16. Global Specific Antiviral Drugs for COVID-19 Market Size in Mild Symptom Patient Growth Rate

Figure 17. Global Specific Antiviral Drugs for COVID-19 Market Size in Critically Ill Patient Growth Rate

Figure 18. Funding/Investment

Figure 19. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Regions 2022-2028

Figure 20. United States Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)

Figure 21. China Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)

Figure 22. Europe Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)

Figure 23. Rest of World Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)

Figure 24. United States Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027

Figure 25. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027

Figure 26. China Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027

Figure 27. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027

Figure 28. Europe Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027

Figure 29. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027

Figure 30. Rest of World Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027

Figure 31. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027